64 related articles for article (PubMed ID: 14660159)
1. Effects of illicit drug use on adherence to prescribed antiretroviral medication.
Rosen MI; Rigsby MO; Dieckhaus KD; Cramer JA
Am J Addict; 2003; 12(5):455-8. PubMed ID: 14660159
[TBL] [Abstract][Full Text] [Related]
2. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
[TBL] [Abstract][Full Text] [Related]
3. Improved adherence with contingency management.
Rosen MI; Dieckhaus K; McMahon TJ; Valdes B; Petry NM; Cramer J; Rounsaville B
AIDS Patient Care STDS; 2007 Jan; 21(1):30-40. PubMed ID: 17263651
[TBL] [Abstract][Full Text] [Related]
4. Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy.
Gebo KA; Keruly J; Moore RD
J Gen Intern Med; 2003 Feb; 18(2):104-11. PubMed ID: 12542584
[TBL] [Abstract][Full Text] [Related]
5. Patient-clinician relationships and treatment system effects on HIV medication adherence.
Ingersoll KS; Heckman CJ
AIDS Behav; 2005 Mar; 9(1):89-101. PubMed ID: 15812616
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy.
Shuter J; Bernstein SL
Nicotine Tob Res; 2008 Apr; 10(4):731-6. PubMed ID: 18418794
[TBL] [Abstract][Full Text] [Related]
7. Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.
De Boni RB; Shepherd BE; Grinsztejn B; Cesar C; Cortés C; Padgett D; Gotuzzo E; Belaunzarán-Zamudio PF; Rebeiro PF; Duda SN; McGowan CC
AIDS Behav; 2016 Nov; 20(11):2692-2699. PubMed ID: 27091028
[TBL] [Abstract][Full Text] [Related]
8. Pill taking 'routinization': a critical factor to understanding episodic medication adherence.
Ryan GW; Wagner GJ
AIDS Care; 2003 Dec; 15(6):795-806. PubMed ID: 14617501
[TBL] [Abstract][Full Text] [Related]
9. Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems.
Kumar S; Rao PS; Earla R; Kumar A
Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):343-55. PubMed ID: 25539046
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.
Kamali M; Kelly L; Gervin M; Browne S; Larkin C; O'Callaghan E
Psychiatr Serv; 2001 Feb; 52(2):161-3, 166. PubMed ID: 11157110
[No Abstract] [Full Text] [Related]
11. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
Sullivan PS; Campsmith ML; Nakamura GV; Begley EB; Schulden J; Nakashima AK
PLoS One; 2007 Jun; 2(6):e552. PubMed ID: 17579723
[TBL] [Abstract][Full Text] [Related]
12. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
[TBL] [Abstract][Full Text] [Related]
13. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.
Cohn SE; Umbleja T; Mrus J; Bardeguez AD; Andersen JW; Chesney MA
AIDS Patient Care STDS; 2008 Jan; 22(1):29-40. PubMed ID: 18442305
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.
Reback CJ; Larkins S; Shoptaw S
AIDS Care; 2003 Dec; 15(6):775-85. PubMed ID: 14617499
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA.
Murphy DA; Wilson CM; Durako SJ; Muenz LR; Belzer M;
AIDS Care; 2001 Feb; 13(1):27-40. PubMed ID: 11177463
[TBL] [Abstract][Full Text] [Related]
16. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations.
Bova CA; Fennie KP; Knafl GJ; Dieckhaus KD; Watrous E; Williams AB
AIDS Behav; 2005 Mar; 9(1):103-10. PubMed ID: 15812617
[TBL] [Abstract][Full Text] [Related]
17. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
[TBL] [Abstract][Full Text] [Related]
18. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
Teixeira C; Dourado Mde L; Santos MP; Brites C
AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
[TBL] [Abstract][Full Text] [Related]
19. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project.
Johnson MO; Catz SL; Remien RH; Rotheram-Borus MJ; Morin SF; Charlebois E; Gore-Felton C; Goldsten RB; Wolfe H; Lightfoot M; Chesney MA;
AIDS Patient Care STDS; 2003 Dec; 17(12):645-56. PubMed ID: 14746658
[TBL] [Abstract][Full Text] [Related]
20. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
Grierson J; Koelmeyer RL; Smith A; Pitts M
HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
